John Apostolidis
Dammam, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Role of consolidative radiotherapy in preventing relapses and subsequent salvage ASCT in early-stage classic Hodgkin lymphoma.
Journal: Bone marrow transplantation
Published: January 11, 2026
Endovascular management of iatrogenic arterial injury post bone marrow biopsy: A report of 3 cases.
Journal: Radiology case reports
Published: November 14, 2022
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Journal: Hematological oncology
Published: May 02, 2022
Promising activity of single agent nivolumab followed by low-dose whole brain radiotherapy in isolated central nervous system relapse of Hodgkin lymphoma.
Journal: Leukemia & lymphoma
Published: August 12, 2021
Allogeneic Stem Cell Transplantation in Patients with High-Risk Multiple Myeloma: Utopia or Continuous Challenge in Aiming for Cure?
Journal: Current treatment options in oncology
Published: April 30, 2021
Favorable Outcome After Adjuvant Involved-Field Radiotherapy After Autologous Hematopoietic Stem-Cell Transplantation in Patients With High-Risk Relapsed/Refractory Lymphoma: A Single-Center Experience.
Journal: Clinical lymphoma, myeloma & leukemia
Published: July 21, 2020
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.
Journal: Saudi journal of medicine & medical sciences
Published: June 29, 2020
Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma.
Journal: Journal of immunology research
Published: June 23, 2020
A case of systemic precursor T-cell lymphoblastic lymphoma presenting with single tooth mobility.
Journal: SAGE open medical case reports
Published: January 30, 2020
Follicular lymphoma: Update on management and emerging therapies at the dawn of the new decade.
Journal: Hematological oncology
Published: December 17, 2019
Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation.
Journal: Bone marrow transplantation
Published: January 08, 2016
Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial".
Journal: Haematologica
Published: November 02, 2015
Last Updated: 09/26/2026